New PET tracers aim to spot tau tangles in rare brain disease
Diagnosis
Completed
This early-phase study tests two new imaging drugs, [18F]ABBV-964i and [18F]ABBV-965i, designed to light up tau protein buildup in the brain during a PET scan. Tau buildup is linked to Progressive Supranuclear Palsy (PSP), a rare movement and thinking disorder. The trial includes…
Phase: EARLY_PHASE1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC